SCHEMBL20426224

SCHEMBL20426224

c1ccc(-n2c3ccccc3c3c4c(ccc32)ccn4-c2cccc(-c3cccnc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.37
▸ CYP2A6 P11509 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ CYP11B2 P19099 2/20 0.34
▸ G6PD P11413 2/20 0.34
▸ CYP19A1 P11511 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20426239 0.91 L3MBTL1 (0.38) MAPTRAB9AALDH1A1L3MBTL1MEN1
SCHEMBL20426240 0.90 KDM4E (0.35) MAPTPDE10ANPC1RAB9ACYP1A2
SCHEMBL15802150 0.86 MAPT (0.37) MAPTCYP2A6PDE10ACYP11B2G6PD
SCHEMBL20426230 0.85 COMT (0.37) MAPTCYP11B2G6PDCYP19A1
SCHEMBL15857151 0.84 MAPT (0.36) MAPTCYP2A6PDE10ACYP11B2G6PD
SCHEMBL15073790 0.83 MAPT (0.40) MAPTCYP2A6PDE10ACYP11B2G6PD
SCHEMBL15857338 0.83 MAPT (0.35) MAPTCYP2A6PDE10ACYP11B2G6PD
SCHEMBL15857416 0.83 MAPT (0.35) MAPTCYP2A6PDE10ACYP11B2G6PD
SCHEMBL20426233 0.83 MAPT (0.36) MAPTCYP11B2G6PDCYP19A1ALDH1A1
SCHEMBL16357383 0.83 MAPT (0.38) MAPTCYP2A6PDE10ACYP11B2G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU MAPT 459/4885CYP2A6 2126/4885PDE10A 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback